Tun Hussein Onn National Eye Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT04654611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Tun Hussein Onn National Eye Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

tafluprost (zioptan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Ocular Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1